COPD Review Note

Specialty: Advanced Clinical Practitioner COPD Review Note Presenting complaint: Patient reports increasing shortness of breath with usual activities and a persistent cough productive of clear sputum over the past two weeks. History of Present Illness: Patient presents for a routine COPD review, but notes a recent worsening of symptoms. They report experiencing increased dyspnea on exertion, now limited to walking short distances on flat ground, whereas previously they could manage stairs. The cough has become more frequent and is consistently producing clear to white sputum. They deny any chest pain or fever. There have been no recent exacerbations requiring hospitalisation or emergency department visits. The patient states they are generally compliant with their medication regimen, though occasionally forgets an inhaler dose when busy. Current Medications: Salbutamol MDI, 2 puffs PRN (up to QDS) Tiotropium bromide DPI, 18 mcg QD Fluticasone propionate/Salmeterol MDI, 250/50 mcg BID Supplemental oxygen at 2 L/min via nasal cannula for nocturnal use and with exertion. Allergies: Penicillin (rash) Past Medical History: Diagnosed with COPD 15 years ago, attributed to a significant smoking history. History of recurrent bronchitis. No other known respiratory conditions. Patient worked as a painter for 20 years, with some exposure to solvents. Social History: Current smoking status: Ex-smoker (quit 5 years ago). Denies current tobacco use. Reports occasional social alcohol consumption (1-2 units per week). Lives in a house with no known environmental triggers or pet dander. Uses a wood-burning stove during winter months. Physical Examination: Vital signs: BP 130/85 mmHg, HR 88 bpm, RR 22 breaths/min, Temp 36.8°C, SpO2 90% on room air, improving to 94% with 2 L/min O2. Weight 75 kg, Height 170 cm, BMI 25.9. Respiratory examination: Mild tachypnoea. Chest expansion symmetrical but reduced. Auscultation reveals diffuse expiratory wheezes and prolonged expiration bilaterally. No crackles. Mild use of accessory muscles noted (sternocleidomastoid activation) during conversation. General appearance: Patient appears mildly distressed with breathing, but is alert and oriented. No peripheral oedema or cyanosis observed. Diagnostic Studies: Recent PFTs (3 months ago): FEV1 45% predicted, FEV1/FVC 0.55 (indicates severe obstruction). Chest X-ray (6 months ago): Hyperinflation, flattened diaphragms, no acute infiltrates. Arterial Blood Gas (1 month ago): pH 7.36, PaCO2 58 mmHg, PaO2 65 mmHg, HCO3 32 mmol/L (compensated respiratory acidosis). Assessment: Patient has severe COPD, currently experiencing a mild exacerbation likely secondary to recent environmental exposure or slight medication non-adherence. Symptoms suggest worsening airway obstruction. Currently stable but requiring close monitoring and potential adjustment to management plan. Patient has demonstrated good understanding of COPD management but requires reinforcement on medication compliance. Identification of triggers or contributing factors: Possible exposure to wood smoke from stove, and admitted occasional non-adherence to inhaler regimen. Patient education provided: Reinforced proper inhaler technique for both MDI and DPI. Discussed importance of consistent medication use, even when feeling well. Provided information on avoiding wood smoke and other irritants. Plan: Medication adjustments or new prescriptions: Increase frequency of Salbutamol MDI to 2 puffs QDS regularly for the next 7 days. Consider a short course of oral corticosteroids (e.g., Prednisolone 30mg daily for 5 days) if symptoms do not improve with increased bronchodilator use. Review need for nebulised bronchodilators if symptoms persist. Non-pharmacological interventions such as pulmonary rehabilitation, smoking cessation, or lifestyle modifications: Reinforce adherence to pulmonary rehabilitation exercises. Discuss strategies for minimising exposure to wood smoke. Continue to encourage smoking cessation (though patient is an ex-smoker, emphasis on maintaining abstinence). Follow-up instructions and monitoring plans: Review in 1 week by telephone to assess symptom improvement. Re-evaluate in clinic in 3 weeks for a comprehensive review of COPD management and PFTs if needed. Advise patient to attend A&E if worsening dyspnoea, fevers, or increased sputum purulence occurs.